NCT03970889

Brief Summary

This study is examining whether the Klue app is effective in detecting missed or late meal boluses in patients with Type 1 diabetes. The app is programmed onto an Apple Watch and will detect potential missed boluses from hand motion. It will send text alerts to the user asking if they have bolused. This is a pilot study and will assess whether there is a change in the number of missed meal boluses in the two weeks prior to each visit. If the findings are significant, this software can be integrated in future closed-loop algorithms for automatic insulin delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

October 12, 2018

Completed
8 months until next milestone

First Posted

Study publicly available on registry

June 3, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2020

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
Last Updated

September 2, 2021

Status Verified

August 1, 2021

Enrollment Period

1.4 years

First QC Date

August 23, 2018

Last Update Submit

August 31, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the number of missed meal boluses

    A missed meal bolus is defined by no insulin dose within 2 hours from the start of the CGM rise.

    The two weeks prior to each study visit

Secondary Outcomes (2)

  • Change in time in range

    data for 1 month prior to each study visit at baseline, 6 weeks and 12 weeks of this 12 week study for each subject

  • Positive predictive value of a Klue meal alert

    All data for the 6 weeks on the Klue intervention arm when Klue is active

Study Arms (2)

Standard Care

NO INTERVENTION

Participants will be in their usual care, wearing a continuous glucose sensor and taking insulin by pump or by pens with memory

Klue

EXPERIMENTAL

Subjects will wear an Apple watch on their dominant hand and receive alerts when eating behavior is detected by the Klue software.

Device: Klue

Interventions

KlueDEVICE

Klue is a software program the uses an Apple watch to detect hand motions which are indicative of eating.

Klue

Eligibility Criteria

Age13 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 13 and over
  • On an insulin pump for at least 3 months and using CGM or using an insulin pen with memory and a CGM
  • Willing to wear a CGM at least 70% of the time while in the study
  • Using an iPhone
  • Willing to wear an Apple watch on their dominant hand while awake
  • Missing or late in giving at least four food boluses in the previous two weeks
  • Understanding and willingness to follow the protocol and sign informed consent
  • Ability to speak, read and write in the language of the investigators

You may not qualify if:

  • Pregnant or lactating
  • A known medical condition that in the judgment of the investigator might interfere with the completion of the protocol
  • Current treatment for a seizure disorder
  • Inpatient psychiatric treatment in the past 6 months
  • Note: Adequately treated thyroid disease and celiac disease do not exclude subjects from enrollment. They may be participating in another trial, if this study is approved by the investigators of the other trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford

Palo Alto, California, 94305, United States

Location

Related Publications (2)

  • Burdick J, Chase HP, Slover RH, Knievel K, Scrimgeour L, Maniatis AK, Klingensmith GJ. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics. 2004 Mar;113(3 Pt 1):e221-4. doi: 10.1542/peds.113.3.e221.

    PMID: 14993580BACKGROUND
  • Olinder AL, Kernell A, Smide B. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes. Pediatr Diabetes. 2009 Apr;10(2):142-8. doi: 10.1111/j.1399-5448.2008.00462.x. Epub 2008 Oct 24.

    PMID: 19175898BACKGROUND

Study Officials

  • Bruce Buckingham, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Subjects are randomized so that half will use the Klue App in the first 6 weeks of the study, and half will use the Klue App during the second 6 weeks of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatric Endocrinology

Study Record Dates

First Submitted

August 23, 2018

First Posted

June 3, 2019

Study Start

October 12, 2018

Primary Completion

March 19, 2020

Study Completion

March 30, 2020

Last Updated

September 2, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations